Advertisement

Picture EBD Group BioPharm America 2021 Digital BPA2021 650x80
Organisation › Details

Bicycle Therapeutics Ltd.

Bicycle Therapeutics is developing a new class of medicines to treat oncology and other important diseases based on its proprietary bicyclic peptide (Bicycle®) product platform. Bicycles® exhibit an affinity and exquisite target specificity usually associated with antibodies, whilst a low molecular weight delivers rapid and deep tissue penetration enabling more efficient tumour targeting. Their peptidic nature provides a “tuneable” pharmacokinetic half-life and a renal route of clearance, avoiding the liver and gastrointestinal tract toxicities often seen with other drug modalities. Bicycle Therapeutics is rapidly advancing towards the clinic with BT1718 and is collaborating in oncology and other areas to realise the full potential of the technology. Bicycle Therapeutics’ unique intellectual property is based on the work initiated at the MRC Laboratory of Molecular Biology in Cambridge, U.K., by the scientific founders of the company, Sir Gregory Winter and Professor Christian Heinis. Bicycle Therapeutics is headquartered in Cambridge, U.K., with a U.S. subsidiary in Cambridge, Massachusetts. *

 

Period Start 2009-10-06 splitoff
  Group Bicycle Therapeutics (Group)
  Predecessor MRC (GB), Laboratory of Molecular Biology (MRC-LMB)
Products Industry Bicycle Drug Conjugates®
  Industry 2 phage display technology
Persons Person Lee, Kevin (Bicycle Therapeutics 201509– CEO before Pfizer + GSK)
  Person 2 Winter, Gregory (MRC + CAT + Domantis)
     
Region Region Babraham, Cambridgeshire
  Country United Kingdom (GB)
  Street Meditrina Building
Babraham Research Campus
  City CB22 3AT Babraham, Cambridgeshire
  Tel +44-1223-497390
    Address record changed: 2020-12-02
     
Basic data Employees n. a.
     
    * Document for �About Section�: Bicycle Therapeutics Ltd.. (11/28/16). "Press Release: Bicycle Therapeutics to Present Preclinical Data at the 28th EORTC-NIC-AACR Molecular Targets and Cancer Therapeutics Symposium". Cambridge, MA & Cambridge.
     
   
Record changed: 2020-01-10

Advertisement

Picture [iito] Plain Stupid Simple 650x80px

More documents for Bicycle Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group Global Partnering Four Events One Price 650x80




» top